Return to homepagePandemic Pact

Developing a Fast-Track COVID-19 Vaccine and an Antibody ELISA Assay with High Specificity and Sensitivity Dr. Jun Wang Dalhousie University, IWK Health Total Project Value: $35,000 Funding Partners: Nova Scotia Health Research Coalition, Nova Scotia Health, Dalhousie University, Dalhousie Medical Research Foundation (DMRF), QEII Health Sciences Centre Foundation, IWK Foundation, IWK Health Centre, Dartmouth General Hospital Foundation (DGHF) Key Words: COVID-19, vaccine, antigen, commercial quadrivalent, influenza virus vaccine, discovery sciences

Grant search

Key facts

  • Disease

    COVID-19

  • start year

    2021

  • Funder

    Research Nova Scotia

  • Principal Investigator

    Dr. Jun Wang

  • Research Location

    N/A

  • Lead Research Institution

    N/A

  • Research Priority Alignment

    N/A

  • Research Category

    Pathogen: natural history, transmission and diagnostics

  • Research Subcategory

    Diagnostics

  • Special Interest Tags

    N/A

  • Study Type

    Non-Clinical

  • Clinical Trial Details

    N/A

  • Broad Policy Alignment

    Pending

  • Age Group

    Not Applicable

  • Vulnerable Population

    Not applicable

  • Occupations of Interest

    Not applicable

Abstract

COVID-19, vaccine, antigen, commercial quadrivalent, influenza virus vaccine, discovery sciences